Huge popliteal arterial aneurysms in Behcet's syndrome: Is ligation an alternative treatment?

被引:2
作者
Goz, Mustafa [1 ]
Cakir, Omer [1 ]
Eren, M. Nesimi [1 ]
机构
[1] Dicle Univ, Fac Med, Dept Cardiovasc Surg, Diyarbakir, Turkey
关键词
aneurysm; Behcet's syndrome; ligation;
D O I
10.2310/6670.2007.00010
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Behcet's syndrome is a multisystemic disease characterized by relapsing uveitis, oral and genital ulcerations, and vascular system involvement. The vascular involvement is seen as venous occlusion, arterial occlusion, and aneurysm formation in this disease, and the surgical treatment of a Behcet's aneurysm has technical difficulties. In this report, we suggest that the huge popliteal artery aneurysm in Behcet's syndrome can be treated by ligation of the popliteal artery. A 58-year-old male patient was admitted to our clinic because of an infrapopliteal great mass at the left leg. Color Doppler ultrasonography and arteriography revealed a 71 X 54 mm aneurysmal dilatation at the distal popliteal artery. Surgery did not reveal any suitable arterial formation for bypass to the distal area of the popliteal artery and tibial arteries. For this reason, we applied ligation of aneurysmal dilatation at the distal popliteal artery. The patient tolerated the operation well and had no signs of ischemia during the postoperative period. In conclusion, especially in aneurysm of arteries such as the popliteal artery, which has critical importance for maintaining distal perfusion, ligation may be a treatment method if there are no other alternatives.
引用
收藏
页码:46 / 48
页数:3
相关论文
共 37 条
[21]   Results of a questionnaire on the treatment of patients with Behcet's syndrome: a trend for more intensive treatment [J].
Turkstra, F. ;
van Vugt, R. M. ;
Dijkmans, B. A. C. ;
Yazici, Y. ;
Yazici, H. .
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2012, 30 (03) :S10-S13
[22]   Rituximab is effective in severe treatment-resistant neurological Behcet's syndrome [J].
Kidd, D. P. .
JOURNAL OF NEUROLOGY, 2015, 262 (12) :2676-2677
[23]   Behcet's Syndrome Complicated with Pulmonary Artery Thrombosis: Response to Tocilizumab Treatment [J].
Eroglu, Didem Sahin ;
Colaklar, Anil ;
Ceran, Alparslan ;
Sezer, Serdar ;
Torgutalp, Murat ;
Kinikli, Gulay .
AKTUELLE RHEUMATOLOGIE, 2021, 46 (05) :485-488
[24]   Treatment of intestinal Behcet's syndrome with chimeric tumour necrosis factor α antibody [J].
Travis, SPL ;
Czajkowski, M ;
McGovern, DPB ;
Watson, RGP ;
Bell, AL .
GUT, 2001, 49 (05) :725-728
[25]   Non-spesific lower extremite pain in Behcet's syndrome and treatment [J].
Ozyuvaci, Emine ;
Altan, Aysel ;
Erturk, Serpil .
TURKDERM-TURKISH ARCHIVES OF DERMATOLOGY AND VENEROLOGY, 2005, 39 (04) :276-278
[26]   Endovascular treatment for rupture of intrahepatic artery aneurysm in a patient with Behcet's syndrome [J].
Jung, Na Young ;
Kim, Seung Kwon ;
Chung, Eun Chul ;
Park, Haewon ;
Cho, Yong Kyun .
AMERICAN JOURNAL OF ROENTGENOLOGY, 2007, 188 (05) :400-402
[27]   Right ventricular thrombus with Behcet's syndrome - Successful treatment with warfarin and immunosuppressive agents [J].
Dogan, Sait M. ;
Birdane, Alparslan ;
Korkmaz, Cengiz ;
Ata, Necmi ;
Timuralp, Bilgin .
TEXAS HEART INSTITUTE JOURNAL, 2007, 34 (03) :360-362
[28]   An evaluation of apremilast for the treatment of adult patients with oral ulcers associated with Behcet's syndrome [J].
Ozdede, Ayse ;
Hatemi, Gulen .
EXPERT OPINION ON PHARMACOTHERAPY, 2021, 22 (12) :1533-1537
[29]   Low-dose natural human interferon-α lozenges in the treatment of Behcet's syndrome [J].
Kilic, Hasan ;
Zeytin, Hasan E. ;
Korkmaz, Cengiz ;
Mat, Cem ;
Gul, Ahmet ;
Cosan, Fulya ;
Dinc, Ayhan ;
Simsek, Ismail ;
Sut, Necdet ;
Yazici, Hasan .
RHEUMATOLOGY, 2009, 48 (11) :1388-1391
[30]   The right place of interleukin-1 inhibitors in the treatment of Behcet's syndrome: a systematic review [J].
Bettiol, Alessandra ;
Silvestri, Elena ;
Di Scala, Gerardo ;
Amedei, Amedeo ;
Becatti, Matteo ;
Fiorillo, Claudia ;
Lopalco, Giuseppe ;
Salvarani, Carlo ;
Cantarini, Luca ;
Soriano, Alessandra ;
Emmi, Giacomo .
RHEUMATOLOGY INTERNATIONAL, 2019, 39 (06) :971-990